Amit A. Kulkarni
City of Hope · 68 works · 3,497 citations · h-index 20
Top works
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- The genomic landscape of small intestine neuroendocrine tumors
- Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
- Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
- Sequencing of C harcot– M arie– T ooth disease genes in a toxic polyneuropathy
- A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
- First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
- Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines
- Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
- The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
- Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
- Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
- Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
- Trajectories of Health Care Contact Days for Patients With Stage IV Non–Small Cell Lung Cancer
- Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
- Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
- Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
- Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment
- Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients